Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario L Marques-Piubelli

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive TumorsLuana Guimaraes Sousa, Daniel J McGrail, Felippe Lazar Neto, et al.
The Journal of Clinical Investigation|July 26, 2022
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responsesGabrielle Romain, Paolo Strati, Ali Rezvan, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 8, 2025
TROP2 Expression in Salivary Gland Adenoid Cystic Carcinoma (ACC) According to Histologic Subtype: Therapeutic ImplicationsJuliana Mota Siqueira, Yoshitsugu Mitani, Mario L Marques-Piubelli, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Oral Oncology|August 27, 2025
Exploring TROP2 expression in oropharyngeal squamous cell carcinoma: Association with prognosis and tumor immune microenvironment compositionJuliana Mota Siqueira, Daniele Heguedusch, Mateus Trinconi Cunha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2023
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic CarcinomaRenata Ferrarotto, Luana G Sousa, Lei Feng, et al.
Molecular Cancer Therapeutics|June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate CancerCheng Wu, Shan Peng, Patrick G Pilié, et al.
Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Virchows Archiv : an International Journal of Pathology|February 23, 2024
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agentsMario L Marques-Piubelli, Bijender Kumar, Rafet Basar, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive TumorsLuana Guimaraes Sousa, Daniel J McGrail, Felippe Lazar Neto, et al.
The Journal of Clinical Investigation|July 26, 2022
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responsesGabrielle Romain, Paolo Strati, Ali Rezvan, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 8, 2025
TROP2 Expression in Salivary Gland Adenoid Cystic Carcinoma (ACC) According to Histologic Subtype: Therapeutic ImplicationsJuliana Mota Siqueira, Yoshitsugu Mitani, Mario L Marques-Piubelli, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Oral Oncology|August 27, 2025
Exploring TROP2 expression in oropharyngeal squamous cell carcinoma: Association with prognosis and tumor immune microenvironment compositionJuliana Mota Siqueira, Daniele Heguedusch, Mateus Trinconi Cunha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2023
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic CarcinomaRenata Ferrarotto, Luana G Sousa, Lei Feng, et al.
Molecular Cancer Therapeutics|June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate CancerCheng Wu, Shan Peng, Patrick G Pilié, et al.
Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Virchows Archiv : an International Journal of Pathology|February 23, 2024
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agentsMario L Marques-Piubelli, Bijender Kumar, Rafet Basar, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Pageof 6